PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
| Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
June 13, 2013 | ISSUE NUMBER 304 VOL 10

Video
Behind the Pharma Top 50
In this short video, Editor-in-Chief William Looney looks at the winners and losers in this year’s Pharm Exec Top 50 Pharma Companies ...Read more

Event
FT Healthcare Conference: Society as Stakeholder
In emerging and developed markets, societal reactions to drug pricing are increasingly important and influential, according to speakers at the 2nd annual Financial Times US healthcare and life sciences conference ...Read More

Marketing
Cost Containment Hits Digital Technologies
Twenty (or arguably, fifty) years into the digital age, there is another revolution sweeping through our industry, one that in many ways has been enabled and accelerated by the digital revolution — the long-dreaded healthcare cost control revolution, now moving front and center on the pharma stage. Bill Drummy reports
...Read more

Comparative Effectiveness
Keeping Time with the National Pharmaceutical Council
Celebrating its 60th year, The National Pharmaceutical Council puts much of its focus today on fostering new ideas and stimulating dialogue among its member companies, other government agencies, and patient advocacy organizations on the subject of Comparative Effectiveness Research
...Read more

Executive Profile
The Friendly Persuasion — An Interview with Fred Hassan
Former Schering-Plough CEO Fred Hassan enlightens us with his 30 years of biopharmaceuticals experience in this exclusive interview
...Read more

Global
China Report
China is the third largest pharmaceutical market in the world and will become the second largest ahead of Japan by 2015. Everything you need to know to do business in the country; key economic sector data and exclusive interviews from regional leaders
...Read more

// Regenerative medicine company Histogenics (Waltham, MA) recruited Peter Greenleaf, formerly of MedImmune, as its new CEO.// Robert Forrester will replace Christoph Westfahl as CEO of biotech company Verastem (Cambridge, MA) on July 1.// Spectrum Pharmaceuticals (Irvine, CA) appointed Kurt Gustafson as Executive VP, Chief Financial Officer, and Principal Accounting Officer.// MPI Research (Mattawan, MI) announced a strategic partnership with inviCRO and 3D Imaging.//

July 17–18: CBI’s Orphan Drug Information Summit
Philadelphia, PA.


August 19–21: 7th Annual Forum on Sunshine and Aggregate Spend
Washington DC.


September 18: Life Sciences Financial Transformation Summit
Philadelphia, PA.


 

Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook
Follow Pharm Exec on Linkedin




Survey
How important is it for pharma marketers to monitor what customers are saying about their companies online?

Click To Vote
Quick Links

FDA Warning Letter for Novartis in Austria

Read the Digital Issue of June’s Pharmaceutical Executive

Takeaways from the Post-Approval Summit